X
19
Novo Nordisk, based in Denmark, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is INSULIN DEGLUDEC, with a corresponding application number 2467879 and regulatory information .
proudly manufactured in the
Novo Nordisk's TRESIBA SOLUTION, medication with 100UNIT/ML of INSULIN DEGLUDEC.